{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:19:25Z","timestamp":1764652765983,"version":"3.46.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The objective of this study was to assess the trade-off between cycle continuation and cancellation in slow ovarian response (SOR) patients, and to evaluate the impact of SOR on embryo developmental potential and clinical pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was performed on 482 patients with PCOS. Patients were stratified into the SOR group (n = 113) and control group (n = 343) in accordance with follicular growth dynamics. Furthermore, data derived from the cycle cancellation group due to SOR (C-SOR group, n = 18) were incorporated for comparative assessment. Clinical outcomes among the respective groups were subsequently subjected to comparative analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The average follicular growth rate in the control group was (1.41 \u00b1 0.45) mm\/day, which was significantly higher than that in both the SOR group (1.09 \u00b1 0.55 mm\/day, P &amp;lt; 0.05) and the C-SOR group (0.25 \u00b1 0.24 mm\/day, P &amp;lt; 0.05). Both SOR and C-SOR groups required significantly more days of Gn and a higher total Gn dose. Notably, supplementation with hCG showed potential for improving ovarian response in patients with SOR. However, if the subsequent follicular growth rate remained below 1.0 mm per day, cycle cancellation was recommended. Although oocytes retrieved was significantly lower in the SOR group than in controls, no intergroup differences were observed in normal fertilization rate, transferable embryo rate, and high-quality embryo rate. Similarly, clinical pregnancy rates after fresh or frozen embryo transfer did not differ between SOR and control groups. However, the SOR group exhibited significantly lower cumulative clinical pregnancy rates (75.22%\n                      <jats:italic>vs<\/jats:italic>\n                      . 88.34%, P &amp;lt; 0.05) and cumulative live birth rates (57.52%\n                      <jats:italic>vs<\/jats:italic>\n                      . 68.8%, P &amp;lt; 0.05) compared with controls. Logistic regression analysis, after adjustment, revealed that the association between SOR and cumulative live birth rates was not statistically significant (adjusted OR = 0.77, 95% CI: 0.47\u20131.25, p = 0.29).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Assessment of follicular growth rate in patients with SOR may facilitate clinical decision-making regarding continuation of ovarian stimulation or cycle cancellation. PCOS patients with SOR may benefit from hCG supplementation to enhance ovarian reactivity, thereby facilitating cycle completion and promoting the chance of clinical pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1679860","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:14:31Z","timestamp":1764652471000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The management of slow ovarian response in PCOS patients and its impact on clinical pregnancy outcomes"],"prefix":"10.3389","volume":"16","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangbai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00361","article-title":"The effect of dose adjustments in a subsequent cycle of women with suboptimal response following conventional ovarian stimulation","volume":"9","author":"Drakopoulos","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13048-024-01437-w","article-title":"Development and validation of a prediction model for suboptimal ovarian response in polycystic ovary syndrome (Pcos) patients undergoing gnrh-antagonist protocol in ivf\/icsi cycles","volume":"17","author":"Xu","year":"2024","journal-title":"J Ovarian Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev316","article-title":"Conventional ovarian stimulation and single embryo transfer for ivf\/icsi. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum Reprod"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201808_15607","article-title":"Rs13405728 is associated with slow ovarian response in assisted reproductive technology","volume":"22","author":"Yin","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00589","article-title":"Understanding ovarian hypo-response to exogenous gonadotropin in ovarian stimulation and its new proposed marker-the follicle-to-oocyte (Foi) index","volume":"9","author":"Alviggi","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-019-0460-4","article-title":"The role of recombinant lh in women with hypo-response to controlled ovarian stimulation: A systematic review and meta-analysis","volume":"17","author":"Conforti","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.795254","article-title":"What does unexpected suboptimal response during ovarian stimulation suggest, an overlooked group","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.938926","article-title":"Clinical features and management of suboptimal ovarian response during in vitro fertilization and embryo transfer: analysis based on a retrospective cohort study","volume":"13","author":"Yan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev150","article-title":"The sub-optimal response to controlled ovarian stimulation: manageable or inevitable","volume":"30","author":"Broekmans","year":"2015","journal-title":"Hum Reprod"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.fertnstert.2015.07.1151","article-title":"Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles","volume":"104","author":"Baker","year":"2015","journal-title":"Fertil Steril"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.06.021","article-title":"Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh versus frozen embryo transfer cycles: A society for assisted reproductive technology clinic outcome system study","volume":"114","author":"Gerber","year":"2020","journal-title":"Fertil Steril"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-014-0253-9","article-title":"Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome","volume":"31","author":"Ryan","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2019.12.007","article-title":"The effect of follicular phase length on cycle outcomes and endometrial development in gonadotrophin ovarian stimulation\/intrauterine insemination cycles","volume":"40","author":"Bakkensen","year":"2020","journal-title":"Reprod BioMed Online"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.10.047","article-title":"Racial and ethnic differences in reproductive potential across the life cycle","volume":"93","author":"Butts","year":"2010","journal-title":"Fertil Steril"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.01.003","article-title":"Recombinant luteinizing hormone supplementation in assisted reproductive technology: A systematic review","volume":"109","author":"Alviggi","year":"2018","journal-title":"Fertil Steril"},{"key":"B17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s43032-021-00683-3","article-title":"A randomized controlled trial on the efficacy and safety of low-dose hcg in a short protocol with gnrh agonist and ovarian stimulation with recombinant fsh (Rfsh) during the follicular phase in infertile women undergoing art","volume":"29","author":"Siristatidis","year":"2022","journal-title":"Reprod Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2014.965675","article-title":"The evaluation of recombinant lh supplementation in patients with suboptimal response to recombinant fsh undergoing ivf treatment with gnrh agonist down-regulation","volume":"31","author":"Yazici Yilmaz","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(11)60007-2","article-title":"Who needs lh in ovarian stimulation","author":"Alviggi","year":"2011","journal-title":"Reprod BioMed Online"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-12-17","article-title":"Recombinant human follicle-stimulating hormone (R-hfsh) plus recombinant luteinizing hormone versus R-hfsh alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis","volume":"12","author":"Lehert","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-7-110","article-title":"Early hcg addition to rfsh for ovarian stimulation in ivf provides better results and the cdna copies of the hcg receptor may be an indicator of successful stimulation","volume":"7","author":"Drakakis","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1827-0","article-title":"The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in pcos patients undergoing ivf cycles: A randomized clinical trial of efficacy and safety","volume":"284","author":"Ashrafi","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (Pcos)","volume":"19","author":"Rotterdam","year":"2004","journal-title":"Hum Reprod"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dez287","article-title":"The impact of embryo quality on singleton birthweight in vitrified-thawed single blastocyst transfer cycles","volume":"35","author":"Zhang","year":"2020","journal-title":"Hum Reprod"},{"key":"B25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12905-015-0223-0","article-title":"Does obesity have detrimental effects on ivf treatment outcomes","volume":"15","author":"Ozekinci","year":"2015","journal-title":"BMC Womens Health"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-024-03386-1","article-title":"Predicting factors of ovarian responses in infertile women with polycystic ovary syndrome undergoing ivf\/icsi","volume":"42","author":"Wang","year":"2025","journal-title":"J Assist Reprod Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3109\/09513591003632100","article-title":"Overweight and obesity negatively affect the outcomes of ovarian stimulation and in vitro fertilisation: A cohort study of 2628 Chinese women","volume":"26","author":"Zhang","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.02.027","article-title":"Ovarian reserve testing: A user\u2019s guide","volume":"217","author":"Tal","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac039","article-title":"Evaluation of female fertility-amh and ovarian reserve testing","volume":"107","author":"Cedars","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000001284","article-title":"Update on assessment of ovarian reserve testing","volume":"79","author":"Osman","year":"2024","journal-title":"Obstet Gynecol Surv"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4784.17.04044-8","article-title":"Individualization of controlled ovarian stimulation in vitro fertilization using ovarian reserve markers","volume":"69","author":"Grisendi","year":"2017","journal-title":"Minerva Ginecol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"B33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3909\/riog0151","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"4","author":"Roe","year":"2011","journal-title":"Rev Obstet Gynecol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Poseidon","year":"2016","journal-title":"Fertil Steril"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh625","article-title":"Recombinant human lh supplementation versus recombinant human fsh (Rfsh) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rfsh. A multicentre, prospective, randomized controlled trial","volume":"20","author":"De Placido","year":"2005","journal-title":"Hum Reprod"},{"key":"B36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/humupd\/dmp012","article-title":"Approaches to improve the diagnosis and management of infertility","volume":"15","author":"Devroey","year":"2009","journal-title":"Hum Reprod Update"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-7-91","article-title":"Hcg priming\u201d Effect in controlled ovarian stimulation through a long protocol","volume":"7","author":"Beretsos","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-10-55","article-title":"Addition of low dose hcg to rfsh benefits older women during ovarian stimulation for ivf","volume":"10","author":"Gomaa","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del284","article-title":"Clinical outcome following stimulation with highly purified hmg or recombinant fsh in patients undergoing ivf: A randomized assessor-blind controlled trial","volume":"21","author":"Andersen","year":"2006","journal-title":"Hum Reprod"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-012-9854-3","article-title":"Efficacy of low dose hcg on oocyte maturity for ovarian stimulation in poor responder women undergoing intracytoplasmic sperm injection cycle: A randomized controlled trial","volume":"29","author":"Madani","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/molehr\/gaq070","article-title":"Gene expression profile in the endometrium on the day of oocyte retrieval after ovarian stimulation with low-dose hcg in the follicular phase","volume":"17","author":"Blockeel","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab065","article-title":"Reduced fsh and lh action: implications for medically assisted reproduction","volume":"36","author":"Bosch","year":"2021","journal-title":"Hum Reprod"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/781543","article-title":"The role of overweight and obesity in in vitro fertilization outcomes of poor ovarian responders","volume":"2015","author":"Vural","year":"2015","journal-title":"BioMed Res Int"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.878214","article-title":"The optimal number of oocytes retrieved from pcos patients receiving ivf to obtain associated with maximum cumulative live birth rate and live birth after fresh embryo transfer","volume":"13","author":"Jia","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2023.03.027","article-title":"More is better: oocyte number and cumulative live birth rate","volume":"119","author":"Kim","year":"2023","journal-title":"Fertil Steril"},{"key":"B46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","article-title":"Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection: A multicenter multinational analysis including approximately 15,000 women","volume":"110","author":"Polyzos","year":"2018","journal-title":"Fertil Steril"},{"key":"B47","doi-asserted-by":"publisher","first-page":"8624","DOI":"10.1038\/s41598-022-12495-9","article-title":"Expression and function of the luteinizing hormone choriogonadotropin receptor in human endometrial stromal cells","volume":"12","author":"Mann","year":"2022","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.862500","article-title":"Association between the ratio of ovarian stimulation duration to original follicular phase length and in vitro fertilization outcomes: A novel index to optimise clinical trigger time","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.05.055","article-title":"Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization","volume":"89","author":"Pal","year":"2008","journal-title":"Fertil Steril"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.02.040","article-title":"High rate of aneuploidy in luteinized granulosa cells obtained from follicular fluid in women who underwent controlled ovarian hyperstimulation","volume":"84","author":"Kaleli","year":"2005","journal-title":"Fertil Steril"},{"key":"B51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/humrep\/dex334","article-title":"The number of oocytes retrieved during ivf: A balance between efficacy and safety","volume":"33","author":"Magnusson","year":"2018","journal-title":"Hum Reprod"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1679860\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:14:33Z","timestamp":1764652473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1679860\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":51,"alternative-id":["10.3389\/fendo.2025.1679860"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1679860","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"article-number":"1679860"}}